SCHEMBL1124987

SCHEMBL1124987

CC(C)(C(=O)O)c1cccc(CBr)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.50
CYP1A2 P05177 1/20 0.50
LTB4R Q15722 4/20 0.46
LTB4R2 Q9NPC1 4/20 0.46
CYP4F2 P78329 2/20 0.42
CYP4A11 Q02928 2/20 0.42
MAP4K4 O95819 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
TRPA1 O75762 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
AKT1 P31749 1/20 0.38
PTGDR Q13258 1/20 0.38
HIF1A Q16665 1/20 0.38
MEN1 O00255 1/20 0.38
APP P05067 1/20 0.38
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15504953 0.86 CYP1A2 (0.43) CYP2C19CYP1A2LTB4RLTB4R2CYP4F2
SCHEMBL129672 0.86 CYP2C19 (0.53) CYP2C19CYP1A2LTB4RLTB4R2CYP4F2
SCHEMBL186895 0.83 CYP2C19 (0.48) CYP2C19CYP1A2KMT2AMAPTTRPA1
SCHEMBL129671 0.83 CYP2C19 (0.50) CYP2C19CYP1A2LTB4RLTB4R2CYP4F2
SCHEMBL15504951 0.82 CYP4F2 (0.45) CYP2C19CYP1A2CYP4F2CYP4A11KMT2A
SCHEMBL2060545 0.82 CYP2C19 (0.47) CYP2C19CYP1A2CYP4F2CYP4A11KMT2A
SCHEMBL31477275 0.81 CYP2C19 (0.49) CYP2C19CYP1A2LTB4RLTB4R2CYP4F2
SCHEMBL2060663 0.80 CNR2 (0.45) CYP2C19CYP1A2CYP4F2CYP4A11ALDH1A1
SCHEMBL2640714 0.80 CYP1A2 (0.44) CYP2C19CYP1A2CYP4F2CYP4A11KMT2A
SCHEMBL479996 0.78 CES2 (0.46) LTB4RLTB4R2MAP4K4KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2284157-A1 Quinolines useful in treating cardiovascular disease Wyeth (US) 2011-02-16 EP disclosed